Journal of Substance Abuse Treatment
Volume 30, Issue 1 , Pages 63-72 , January 2006

Heroin maintenance treatment for chronic heroin-dependent individuals: A Cochrane systematic review of effectiveness

  • Marica Ferri, M.Sc.

      Affiliations

    • Agency of Public Health, Latium Region, Via di Santa Costanza 53, 00198 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 83060336; fax: +39 06 83060463.
    • ,
  • Marina Davoli, M.D.

      Affiliations

    • Department of Epidemiology ASL RME, Via di Santa Costanza 53, 00198 Rome, Italy
    • Tel.: +39 06 83060483; fax: +39 06 83060463.
    • ,
  • Carlo A. Perucci, M.D.

      Affiliations

    • Department of Epidemiology ASL RME, Via di Santa Costanza 53, 00198 Rome, Italy
    • Tel.: +39 06 83060485; fax: +39 06 83060463.

Received 5 January 2005 ,Revised 16 January 2005 ,Accepted 27 September 2005.

References 

  1. Bargagli A, Sperati A, Davoli M, Perucci CA, Vincente J, Hartnoll R, et al. Mortality among problem drug users in Europe: A project of the EMCDDA. Heroin Addiction and Related Clinical Problems. 2002;4:5–12
  2. Battersby M, Farrell M, Gossop M, Robson P, Strang J. Horse trading: Prescribing injectable opiates to opiate addicts—A descriptive study. Drug and Alcohol Dependence. 1992;35–42
  3. Bosch X. Spain authorises clinical trial on heroin maintenance therapy. Lancet. 2001;357:1347
  4. Central Committee on the Treatment of Heroin Addicts (CCBH). Medical co-prescription of heroin. Two randomized trials. 2002;Utrecht, Netherlands. Available at: www.ccbh.nl
  5. Clark N, Lintzeris N, Gijsbers A, Whelan G, Dunlop A, Ritter A, et al. LAAM maintenance vs methadone maintenance for heroin dependence. Cochrane Review In: The Cochrane library, Issue 3. Oxford: Update Software; 2003;
  6. Clarke M, Oxman AD. Cochrane reviewers' handbook 4.2.0. In: The Cochrane library, Issue 2. Oxford: Update Software; 2003;
  7. Cooper-Mahkorn D. German doctors vote to prescribe heroin to misusers. British Medical Journal. 1998;316:1037
  8. Derogatis LR. SCL-90-R: Administration, scoring and procedures. Manual II. Towsen, MD: Clinical Psychometric Research; 1983;
  9. Davoli M, Perucci CA, Rapiti E, Bargagli AM, D'Ippoliti D, Forestiere F, et al. A persistent rise in mortality among injection drug users in Rome, 1980 through 1992. American Journal of Public Health. 1997;87:851–853
  10. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Review In: The Cochrane library, Issue 3. Oxford: Update Software; 2003;
  11. Farrell M, Hall W. The Swiss heroin trials: Testing alternative approaches. British Medical Journal. 1998;316:639
  12. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependents. Cochrane Review In: The Cochrane library, Issue 3. Oxford: Update Software; 2003;
  13. Fischer B, Rehm J. The case for a heroin substitution trial in Canada. Canadian Journal of Public Health. 1997;88:367–370
  14. Fischer G, Reinhold J, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, et al. Comparison of methadone and slow release morphine maintenance in pregnant addicts. Addiction. 1999;94:231–239
  15. Ghodse AH, Creighton FJ, Bhat AV. Comparison of oral preparations of heroin and methadone to stabilise opiate misusers as inpatients. British Medical Journal. 1990;300:719–720
  16. Haemmig RB, Tschacher W. Effects of high-dose heroin vs morphine in intravenous drug users: A randomised double-blind crossover study. Journal of Psychoactive Drugs. 2001;33:105–110
  17. Hartnoll RL, Mitcheson MC, Battersby A, Brown G, Ellis M, Fleming P, et al. Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry. 1980;37:877–884
  18. Hendriks VM, van den Brink W, Blanken P, Bosman IJ, van Ree JM. Heroin self-administration by means of ‘chasing the dragon’? Pharmacodynamics and bioavailability of inhaled heroin. European Neuropsychopharmacology. 2001;11:241–252
  19. Jasinski DR, Preston KL. Comparison of intravenously administered methadone, morphine and heroin. Drug and Alcohol Dependence. 1986;17:301–310
  20. Krausz M, Uchtenhagen A, van den Brink W. Medizinish indizierte heroinverschreibung in der behandlung drogenabhangiger (Medically indicated heroin prescription in the treatment of drug addicts), Sucht. 1999;45:171–186
  21. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Strang J. The Maudsley Addiction Profile. A brief instrument for treatment outcome research. Development and user manual. London: National Addiction Centre/Institute of Psychiatry Addiction Sciences; 1998;
  22. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Review In: The Cochrane library, Issue 3. Oxford: Update Software; 2003;
  23. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Review In: The Cochrane library, Issue 3. Oxford: Update Software; 2003;
  24. McCusker C, Davies M. Prescribing drug of choice to illicit heroin users: The experience of a U.K. community drug team. Journal of Substance Abuse Treatment. 1996;13:521–531
  25. McLellan T, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. Journal of American Medical Association. 2000;284:1689–1695
  26. Mello NK, Mendelson JH, Kuehnle JC, Sellers MS. Operant analysis of human heroin self-administration and the effects of naltrexone. Journal of Pharmacology and Experimental Therapeutics. 1981;216:45–54
  27. Metrebian N, Shanahan W, Stimson G. Heroin prescribing in the United Kingdom: An overview. European Addiction Research. 1996;2:194–200
  28. Metrebian N, Shanahan W, Wells B, Stimson G. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions. Medical Journal of Australia. 1998;168:596–600
  29. Moldovanyi A, Ladewig D, Affentranger P, Natsch C, Stohler R. Morphine maintenance treatment of opioid-dependent out-patients. European Addiction Research. 1996;2:208–212
  30. O'Brien CP. A range of research-based pharmacotherapies for addiction. Science. 1997;278:66–70
  31. Oppenheimer E, Stimson GV. Seven year follow-up of heroin addicts: Life histories summarised. Drug and Alcohol Dependence. 1982;9:153–159
  32. Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal. 1998;317:13–18
  33. Pocock JS. Clinical trials. A practical approach. Chichester: John Wiley & Sons; 1985;
  34. Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet. 2001;358:1417–1420
  35. Schellings R, Kessels AG, ter Riet G, Sturmans F. The Zelen design may be the best choice for a heroin-provision experiment. Journal of Clinical Epidemiology. 1999;52:503–507
  36. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of American Medical Association. 2000;283:1303–1310
  37. Strang J, Ruben S, Farrell M, Gossop M. In:  Strang J,  Gossop M editor. Heroin addiction and drug policy: The British system. Oxford: Oxford University Press; 1994;p. 192–206
  38. Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, et al. Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome. Addiction. 2000;95:1631–1645
  39. Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blattler R, Pfeifer S. In: Prescription of narcotics for heroin addicts. vol.1:Basel: Karger; 1999;
  40. van den Brink W, Hendriks VM, Blanken P, Huijsman IA, van Ree JM. Medical co-prescription of heroin. Two trials. The Netherlands: Central Committee on the treatment of heroin addicts; 2002;
  41. van den Brink W, Hendriks VM, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal. 2003;327:310–316
  42. Venning GR. Trial is needed comparing decriminalisation of heroin with existing policy of prohibition. British Medical Journal. 1998;317:1011
  43. Wodak A. Further studies of heroin treatment are needed. British Medical Journal. 1998;317:1011

PII: S0740-5472(05)00198-4

doi: 10.1016/j.jsat.2005.09.003

Journal of Substance Abuse Treatment
Volume 30, Issue 1 , Pages 63-72 , January 2006

Article Tools